Abstract
Preclinically Effective Menin Inhibitor SNDX-50469 and SNDX-5613-Based Combinations Against MLL1-Rearranged (MLL-r) or NPM1-Mutant AML Models
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have